Active ingredientTetryzoline HClCat. No. P-T079-001CAS 522-48-5Family · Pharmaceutical analytical standards
Tetryzoline
An imidazoline decongestant that stimulates alpha-adrenergic receptors: patented in 1954 and in use since 1959, it narrows small blood vessels and is used in eye drops and nasal sprays for red eyes and a blocked nose. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.
Did you know?It is also known as tetrahydrozoline: the name sums up its structure, a tetrahydronaphthalene ring joined to an imidazoline ring.
Go to the active ingredient →Active ingredientTetryzoline HClCat. No. P-T079-001CAS 522-48-5
Pharmacopoeial impurityTetrahydrozoline USP Related Compound ACat. No. P-T079-002CAS 56536-96-0
Pharmacopoeial impurityTetrahydrozoline USP Related Compound BCat. No. P-T079-003CAS 945389-41-3
Pharmacopoeial impurityTetrahydrozoline USP Related Compound CCat. No. P-T079-004CAS 1914-65-4
Pharmacopoeial impurityTetrahydrozoline USP Related Compound ECat. No. P-T079-005CAS 84460-89-9
NitrosamineN-Nitroso TetryzolineCat. No. P-T079-006
ImpurityTetryzoline Impurity 1Cat. No. P-T079-007CAS 17502-86-2
ImpurityN-(2-aminoethyl)tetralin-1-carboxamide hydrochlorideCat. No. P-T079-008CAS 1828966-95-5No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceTetryzoline hydrochloride CRSEDQM code Y0000460Family TetryzolineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.